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ABSTRACT
We studied the effect of two types of mesoporous silica nanoparticles, MCM-41 and SBA-15, on mitochondrial O2 consumption (respiration)
in HL-60 (myeloid) cells, Jurkat (lymphoid) cells, and isolated mitochondria. SBA-15 inhibited cellular respiration at 25–500 µg/mL; the inhibition
was concentration-dependent and time-dependent. The cellular ATP profile paralleled that of respiration. MCM-41 had no noticeable effect on
respiration rate. In cells depleted of metabolic fuels, 50 µg/mL SBA-15 delayed the onset of glucose-supported respiration by 12 min and 200
µg/mL SBA-15 by 34 min; MCM-41 also delayed the onset of glucose-supported respiration. Neither SBA-15 nor MCM-41 affected cellular
glutathione. Both nanoparticles inhibited respiration of isolated mitochondria and submitochondrial particles.
Nanoparticles have been suggested for cellular drug (or gene)
delivery and other important biological applications.1–3
Consequently, their potential adverse effects on human health
have attracted much attention. The term “nanotoxicology”
is now commonly used to describe cellular injuries produced
by various nanoparticles.2 For example, treatment of T-cells
with multiwalled carbon nanotubes (20–40 nm diameter and
1–5 µm length) caused dose- and time-dependent apoptosis.4
Water-soluble fullerene nanoparticles can transfer electrons
to O2, producing reactive O2 species (ROS) and lipid
membrane peroxidation.5 Silica nanoparticles induce mito-
chondrial oxidative stress and deplete cellular glutathione
(GSH).6 Many of these cytotoxic effects can be visually
confirmed by atomic force microscopy.7
Cytotoxins block cellular respiration (mitochondrial O2
consumption) by a variety of mechanisms. In toxin-induced
apoptosis,8–10 the intracellular process is mediated by a series
of cysteine, aspartate-directed proteases, termed caspases.
Caspase activation leads to mitochondrial dysfunction, which
includes opening of the permeability transition pores, collapse
of the mitochondrial membrane potential, and uncoupling
of oxidative phosphorylation.11 Other potential deleterious
actions include toxin-induced direct mitochondrial injury,
inhibition of metabolism, and blocking mitochondrial fuel
delivery.
Systematic investigation of the cytotoxicity of nano-
materials is essential prior to their medical application.
Considering the special behavior at nanoscale, changes in
particle material, size, shape, surface area, aggregation, and
conjugation are expected to alter nanoparticles’ biological
effects. MCM-41 nanospheres have been shown to efficiently
enter cells and induce significant toxicity.12,13 This study
investigates the effects of MCM-41 and SBA-15 mesoporous
silica nanoparticles on cellular bioenergetics (cellular respira-
tion and ATP content). These nanomaterials are currently
considered as potential vehicles for drug and neurotransmitter
deliveries.14–16 We show that the mesoporous silica nano-
materials affect mitochondrial function, in a manner depend-
ent on their physical properties.
MCM-41 and SBA-15 mesoporous silica nanoparticles
were made by supramolecular self-assembly techniques under
base- and acid-catalyzed conditions, respectively.17–19 The
transmission electron microscopy (TEM) images (Figure 1)
show MCM-41 materials are rather regular spheres (300–650
nm in diameter), while SBA-15 materials are irregularly
shaped with dimensions of hundreds of nanometers. The
materials were characterized by powder X-ray diffraction
(XRD), which showed sharp low-angle Bragg reflections and
highly ordered mesostructures (see Supporting Information,
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Figure S1). The lattice spacing for MCM-41 was ∼44 Å
and that for SBA-15 was ∼106 Å. The nitrogen gas
adsorption isotherm (NGAI) profiles for both materials
showed type IV isotherms with steep capillary condensation
steps (see Supporting Information, Figures S2A and S3A),
confirming highly ordered mesoporous particles with large
surface areas. From the NGAI measurements, MCM-41 and
SBA-15 have BET surface areas of 821 and 506 m2/g,
respectively, and monodisperse pore size distributions with
BJH (Barrett–Joyner–Halenda) pore diameters of 31 and 55
Å, respectively (see Supporting Information, Figures S2B
and S3B). From measured lattice spacings and pore diam-
eters, the wall thicknesses of MCM-41 and SBA-15 were
13 and 51 Å, respectively.
Composition of the materials was checked using 29Si CP-
MAS solid-state NMR spectroscopy, which showed Q3 and
Q4 silicon sites centered at about -101 and -115 ppm,
respectively. The 13C CP-MAS solid-state NMR spectroscopy
did not show peaks corresponding to residual unhydrolyzed
ethoxy groups and surfactant templates. These results are
consistent with reported physical properties for such materi-
als.17–19
Oxygen concentration was measured from the decay of
phosphorescence from a palladium phosphor.20 Cells (0.5 ×
106/mL) were suspended in media plus 2 µM Pd phosphor
and 0.5% fat-free bovine serum albumin with and without
500 µg/mL MCM-41 or SBA-15, and placed in closed 1 mL
vessels for O2 measurement. Results are in Figure 2A. The
rate of cellular mitochondrial O2 consumption (k, in µM O2/
min) is the negative of the slope in a plot of [O2] vs t. For
untreated cells, k ) 0.64 (r2 ) 0.988); for cells treated with
MCM-41, k ) 0.66 (r2 ) 0.990); for cells treated with SBA-
15, k ) 0.32 (r2 ) 0.961, 49% inhibition). The k-values for
cell-free media containing MCM-41 or SBA-15 were 0.04
or -0.01, respectively (similar to instrument drift). Thus,
the interaction between nanoparticles and O2 or Pd phosphor
is negligible.
Dependence of the inhibition on SBA-15 dosing is shown
in Figure 2B. The k-value (µM O2/min) for untreated cells
was 0.78 (r2 ) 0.987), for cells treated with 50 µg/mL 0.58
(r2 ) 0.984, 26% inhibition), for cells treated with 100 µg/
mL 0.52 (r2 ) 0.990, 33% inhibition), for cells treated with
200 µg/mL 0.50 (r2 ) 0.959, 36% inhibition), and for cells
treated with 300 µg/mL 0.46 (r2 ) 0.945, 41% inhibition).
In another experiment, the inhibition with 25 µg/mL SBA-
15 was 10%. We have fitted percent inhibition (I) to the
function Rd/( + d), where d is the dose in µg/mL. The
best-fit curve (r2 ) 0.986, see Supporting Information, Figure
S4) gives R ) 57.8% (maximum inhibition) and  ) 102.3
µg/mL (dose giving to ½ maximum inhibition). Assuming
that I ) 0 for zero dose and I approaches 100% for a very
large dose, we also fitted the results to I ) 100[1 -
exp(-adb)]; least-squares fitting (r2 ) 0.955) gives a )
0.0429 and b ) 0.4454.
To measure dependence of I on incubation time with SBA-
15, every hour samples were withdrawn simultaneously from
four conditions, either untreated or treated with 50, 100, or
200 µg/mL SBA-15. Oxygen measurements were then made
every minute alternately on all four samples for about an
hour, giving the results of Figure 2C (results for 100 µM
not shown for clarity). The incubation with the particles thus
continued during the measurements. The k-values for all
conditions, with statistical errors from linear fitting, are given
in Table 1 and Figure 5 in Supporting Information. For 50
µg/mL SBA-15, the inhibitions I at hours 1–6 were 27%,
36%, 9%, 53%, 0%, and 0%. For 100 µg/mL SBA-15,
I-values at hours 1–6 were 25%, 25%, 26%, 68%, 0%, and
0%. For 200 µg/mL SBA-15, I-values at hours 1–6 were
64%, 38%, 34%, 51%, 0%, and 46%. Because the statistical
errors in k-values are ∼10% (see Supporting Information),
there is a large uncertainty in each calculated I-value.
Therefore, we do not consider a big fluctuation in I from
hour h to hour h + 1 as meaningful, unless it persists at
hour h + 2. In another experiment (Table 2 in Supporting
Information), inhibition was again significantly greater for
higher concentrations and disappeared after a few hours
at lower concentrations. Thus, the inhibition is time-
dependent as well as dose-dependent, showing recovery with
lower concentrations. Cyanide gave almost complete per-
manent inhibition; after 2 h, the inhibition averaged >94%
(Table 2 in Supporting Information), showing O2 consump-
tion was due to oxidations in the mitochondrial respiratory
chain.
Figure 1. TEM images of MCM-41 and SBA-15.
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Figure 2D shows the effects of 50, 100, and 200 µg/mL
MCM-41 on Jurkat cell respiration. The k-value (µM O2/
min) for untreated cells was 0.46 (r2 ) 0.977), for cells
treated with 50 µg/mL 0.45 (r2 ) 0.990), for cells treated
with 100 µg/mL 0.48 (r2 ) 0.981), and for cells treated with
200 µg/mL 0.46 (r2 ) 0.959). Thus, MCM-41 does not
inhibit respiration at any of the concentrations used. For all
conditions, respiration was almost completely inhibited by
10 mM NaCN, injected at hour 3.
In other experiments, Jurkat cells were incubated at 37
°C in phosphate-buffered saline (PBS) for 12 h to deplete
endogenous metabolic fuels. Then O2 measurements were
performed on (1) cells without glucose, (2) cells with 100
µM glucose, (3) cells with 100 µM glucose plus 50 µg/mL
nanoparticles, and (4) cells with 100 µM glucose plus 200
µg/mL nanoparticles. Cell viability at the time of O2
measurement was >90%. For all conditions, NaCN was
added to terminate respiration when [O2] approached 40 µΜ.
Figure 3 shows the effect of SBA-15, with lines being the
best fits to the three-line function:
[O2]) a+ bt, t < t1
[O2]) c+ dt, t1e te t2
[O2]) e, t > t2
Here, t1 is the onset of accelerated respiration; t2 is just after
the time of NaCN addition. Continuity requires a + bt1 ) c
+ dt1, and c + dt2 ) e, reducing the number of parameters
from seven to five. The rate of respiration, k, is equal to -b
for t < t1 and -d for t1 e t e t2.
In the absence of glucose, the k-values (µM O2/min) were
0.18 for 0 < t < 56 min, 0.38 for 56 < t < 300 min (r2 >
0.995, 2.1-fold increment), and 0.02 for t > 300 min (95%
inhibition by NaCN). Presumably, the increased respiration
after t1 ) 56 min was due to residual intracellular nutrients
and fatty acids in the albumin preparation. In the presence
of glucose without SBA-15, the k-values were 0.39 for 0 <
t < 68 min, 0.94 for 68 < t < 147 min (r2 > 0.998, 2.4-fold
Figure 2. Effects of silica nanoparticles on Jurkat cell respiration. Respiration rate (k) is the negative of the slope when plotting [O2] vs t,
measured in a closed vessel. (A) Respiration was measured in cells (0.5 × 106 per mL) without (open circles and dashed line) or with 500
µg/mL MCM-41 (filled circles and line) or SBA-15 (filled diamonds and line). Open diamonds and open squares are for medium + SBA-
15 and medium + MCM-41, respectively. Lines are linear fits. (B) Respiration was measured in cells (0.5 × 106 per mL) without (open
circles) or with 50 (closed circles), 100 (diamonds), 200 (triangles), or 300 (squares) µg/mL SBA-15. Lines are linear fits. (C) Cells were
suspended at 106 cells per mL without or with 50, 100, or 200 µg/mL SBA-15. Samples of all four were taken simultaneously every hour
for measurement of [O2], alternately on each of the four samples, with results shown. Open circles and dashed line ) untreated, closed
circles and line ) 50, crosses and line ) 200; 100 µg/mL not shown. (D) [O2] vs t for cells (0.5 × 106 per mL) exposed to 0 (open circles),
50 (closed circles), 100 (diamonds), or 200 (triangles) µg/mL MCM-41. Lines are linear fits. Injections of 10 mM NaCN at ∼185 min
halted respiration.
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increment), and 0.02 for t > 147 min (98% inhibition by
NaCN). In the presence of glucose and 50 µg/mL SBA-15,
the k-values were 0.29 for 0 < t < 80 min, 0.53 for 80 < t
< 230 min (r2 > 0.998, 1.8-fold increment), and 0.02 for t
> 230 min (96% inhibition by NaCN). In the presence of
glucose and 200 µg/mL SBA-15, the k values were 0.35 for
0 < t < 102 min, 0.42 (r2 > 0.998, 1.2-fold increment) for
102 < t < 277 min, and 0.04 for t > 277 min (90% inhibition
by NaCN). Thus, t1 (onset of accelerated respiration) with
glucose alone was 68 min, with glucose plus 50 µg/mL SBA-
15 80 min (12-min delay), and with glucose plus 200 µg/
mL SBA-15 102 min (34-min delay). Moreover, glucose-
supported respiration was inhibited 44% by 50 µg/mL SBA-
15 and 56% by 200 µg/mL SBA-15.
A similar set of experiments was carried out with MCM-
41 (see Supporting Information, Figure S6). In the absence
of glucose, no appreciable increase in respiration rate was
observed; the best-fit value of t1 was 26 min. The k-value
(µM O2/min) for 26 < t < 310 min was 0.18 (r2 > 0.981)
and for t > 310 min 0.03 (83% inhibition by NaCN). In the
presence of glucose without MCM-41, t1 was 22 min and k
for 22 < t < 296 min was 0.40 (r2 > 0.995) and for t > 296
min 0.02 (95% inhibition by NaCN). In the presence of
glucose plus 50 µg/mL MCM-41, t1 was 32 min and k for
32 < t < 301 min was 0.47 (r2 > 0.997) and for t > 301
min 0.01 (98% inhibition by NaCN). With 200 µg/mL SBA-
15, t1 was 49 min and k was 0.40 (r2 > 0.996) for 49 < t <
307 min and 0.05 for t > 310 min (88% inhibition by NaCN).
In all conditions with glucose, the k-values were 0.42 ( 0.04
(2.3-fold that without glucose) and reduced to almost zero
by NaCN. Thus, MCM-41 had no noticeable effect on
respiration rate, but the onset of accelerated respiration was
delayed by 10 min by 50 µg/mL MCM-41, and by 27 min
by 200 µg/mL MCM-41. Although both SBA-15 and MCM-
41 delayed glucose-supported respiration in cells previously
depleted of nutrients, only SBA-15 inhibited respiration.
Experiments similar to those on Jurkat cells were per-
formed on HL-60 cells. The effects of SBA-15 on respiration
are shown in Figure 4. Figure 4A presents [O2] vs t for
untreated cells and cells treated with 50, 100, or 200 µg/
mL. The k-value (µM O2/min) for untreated cells was 0.44
(r2 > 0.995); for cells treated with 50 µg/mL, 0.29 (r2 )
0.975, 34% inhibition); for cells treated with 100 µg/mL,
0.28 (r2 ) 0.982, 36% inhibition); and for cells treated with
Figure 3. Effects of SBA-15 on glucose-supported respiration in Jurkat cells depleted of metabolic fuels. Cells (106 per mL) were washed
twice in PBS and incubated at 37 °C in PBS for 12 h to deplete endogenous metabolic fuels. The cells were then suspended in PBS, 2 µM
Pd phosphor, and 0.5% albumin with and without 100 µM glucose and 50 or 200 µg/mL SBA-15. When used, glucose and nanoparticles
were both added at t ) 0. Other additions were 10 mM NaCN, added when [O2] reached 40 µΜ, which completely stopped O2 consumption,
showing O2 was consumed in the mitochondrial respiratory chain.
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Figure 4. Effects of silica nanoparticles on HL-60 cell respiration. (A) Respiration was measured in cells (0.5 × 106 per mL) without (open
circles) or with 50 (closed circles), 100 (diamonds), or 200 (triangles) µg/mL SBA-15. Minute zero corresponds to the addition of particles.
Best-fit lines are shown; k is the negative of the slope. (B) Cells were suspended at 106 cells per mL without (open circles) or with 50 µg/mL
SBA-15 (closed circles), 200 µg/mL SBA-15 (triangles), or 10 mM NaCN (diamonds). Samples were taken simultaneously every hour for all
conditions and placed in closed containers for measurement of respiration. Values of k, derived from the linear fits (long-dashed for without
SBA-15, short-dashed for 50 µg/mL, solid for 200 µg/mL SBA-15 and for NaCN) are given in Table 3 of Supporting Information. (C) Respiration
was measured in cells (0.5 × 106 per mL) without (open circles) or with 50 (solid triangles), 100 (squares), or 200 (diamonds) µg/mL
MCM-41. Best linear fits are shown. The addition of 10 mM NaCN was at 3 h.
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200 µg/mL, 0.24 (r2 ) 0.954, 46% inhibition). The inhibi-
tions are similar to those measured for Jurkat cells (Figure
2B).
Figure 4B shows how respiration rate varies with incuba-
tion time with SBA-15 at two concentrations. After 1 h,
percent inhibition was 36.0 ( 14.6 (mean ( standard
deviation) at 200 µg/mL and 25.0 ( 10.7 at 50 µg/mL; these
results were similar to those for Jurkat cells, Figure 2C. There
was no sign of recovery out to 7 h. Cyanide inhibited
respiration almost completely after 1 h; the average percent
inhibition was 95.9 ( 3.8. Detailed results are in Table 3 of
Supporting Information.
The effect of MCM-41 on HL-60 respiration (106 cells
per mL) is shown in Figure 4C. The k-value (µM O2/min)
for untreated cells was 0.81 (r2 > 0.984), for cells treated
with 50 µg/mL 0.80 (r2 ) 0.990), for cells treated with 100
µg/mL 0.73 (r2 ) 0.984), and for cells treated with 200 µg/
mL 0.77 (r2 ) 0.983). The k-values for all concentrations
were essentially the same (0.77 ( 0.03) and not significantly
different from the k-values of untreated cells. Apparently,
MCM-41 had minimal effect on HL-60 cell respiration. For
all conditions, O2 consumption was inhibited by 10 mM
NaCN.
We next investigated the effect of nanoparticles on cellular
ATP level. ATP was measured using the luciferin/luciferase
bioluminescence system.8,9 Jurkat and HL-60 cells (0.5 ×
106/mL) were incubated at 37 °C with no addition or with
50 µg/mL SBA-15, 50 µg/mL MCM-41, or 10 mM NaCN.
Samples were taken from each condition at 0.25, 0.5, 1, 2,
and 4 h for ATP determination. Results for Jurkat cells are
shown in Figure 5A. Measured ATP concentrations are
plotted vs incubation time; each is the average of three to
five determinations, with the error bars giving standard
deviations. For untreated cells, the best-fit line, shown
dashed, had a slope (in nanomoles ATP per 0.5 × 106 cells
h-1) of 0.100 ( 0.080 (essentially zero). The slopes were
also zero for cells treated with SBA-15, MCM-41, and
NaCN; their values being 0.078 ( 0.134, -0.079 ( 0.090,
and 0.033 ( 0.051, respectively. Thus, time-average ATP
concentrations were calculated, using six points for untreated
cells and five points (for t > 0) for the other conditions.
They were (mean ( standard deviation, in nanomoles of ATP
per 0.5 × 106 cells) 2.36 ( 0.28 for untreated, 2.24 ( 0.32
for SBA-15, 2.53 ( 0.42 for MCM-41, and 1.45 ( 0.44 for
NaCN. Thus, neither SBA-15 nor MCM-41 at 50 µg/mL
significantly affected cellular ATP over 4 h (other experi-
ments, not shown, extended this to 6 h). Cyanide, on the
other hand, decreased cellular ATP by 39% within 1 h.
Similar results were noted with HL-60 cells (Figure 5B),
although statistical errors were somewhat larger than those
for Jurkat cells. Since the slope was close to zero (0.179 (
0.063 nanomoles of ATP h-1), time averages were calculated,
using six points for untreated cells and five points for the
other conditions. Average cellular ATP levels (mean (
standard deviation, in nanomoles of ATP per 0.5 × 106 cells)
were 2.14 ( 0.33 for untreated cells, 2.31 ( 0.77 for SBA-
15, 2.23 ( 0.66 for MCM-41, and 1.33 ( 0.38 for NaCN.
At 200 µg/mL, SBA-15, but not MCM-41, significantly
diminished cellular ATP (Figure 6A). For untreated HL-60
cells the average ATP level over time (mean ( standard
deviation in nanomoles of ATP per 0.5 × 106 cells) was
0.725 ( 0.054. For MCM-41 treated cells the ATP level
deviated by more than the standard deviation from the level
for untreated cells only once (at hour 4), implying a random
error, rather than a real decrease. Including all points, the
average ATP level for MCM-41 treated cells was 0.661 (
0.116, equal to that for untreated cells within standard error.
For SBA-15 treated cells, the ATP level was 23% lower at
hour 1 (p < 0.04), 41% lower at hour 2 (p < 0.02); decreases
at hours 3–6 were 24%, 14%, 28%, and -2% (i.e., zero).
Figure 5. Effects of silica nanoparticles on cellular ATP. (A) Jurkat
cells (0.5 × 106 per mL) were incubated at 37 °C for indicated
periods of time without additions (open circles) or with 50 µg/mL
SBA-15 (closed circles), 50 µg/mL MCM-41 (triangles), or 10 mM
NaCN (squares). Measured ATP concentrations are plotted vs
incubation time; each is the average of three to five determinations,
with the error bars giving standard deviations. Since the slope of
the best-fit line for untreated cells (dashed) has slope ∼0, time-
average ATP concentrations were calculated. (B) HL-60 cells (0.5
× 106 per mL) were incubated at 37 °C for indicated periods of
time without additions (open circles) or with 50 µg/mL SBA-15
(closed circles), 50 µg/mL MCM-41(triangles), or 10 mM NaCN
squares). The best-fit line (dashed) for untreated cells has a very
small slope, so average ATP levels were calculated as for Jurkat
cells.
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The average decrease between 1 and 5 h was 27%, with full
recovery at hour 6. These results parallel the temporary
inhibition of HL-60 respiration by SBA-15 (Figure 4B).
The above experiment was repeated in the presence of 10
mM NaCN (Figure 6B). Cyanide decreased cellular ATP in
all conditions. The time-average cellular ATP level for t >
0 (mean ( standard deviation in nanomoles of ATP per 0.5
× 106 cells) with NaCN alone was 0.434 ( 0.093, with
NaCN plus MCM-41 0.377 ( 0.076 (13% decrease, probably
not statistically significant), and with NaCN plus SBA-15
0.232 ( 0.102 (47% decrease, which is significant). This
shows that ATP hydrolysis (consumption) occurred in all
conditions, and even faster with SBA-15 present.
The effects of nanoparticles on cellular GSH were also
studied. Jurkat and HL-60 cells (106 per mL) were left
untreated or treated at 37 °C for up to 4 h with 50 µg/mL
SBA-15 or MCM-41. Samples were taken every hour for
measurement of cellular GSH. The results, shown in Figure
S9 (Supporting Information), suggest that the effect of these
nanoparticles on cellular GSH was minimal. In other
experiments, cells were incubated at 37 °C for 6 h without
or with 50 µg/mL SBA-15, 50 µg/mL MCM-41, or 5 mM
NEM (which rapidly reacts with GSH, preventing mBBr
labeling). Results (mean ( standard deviation for three
measurements in each case) are shown in Figure S9C (Jurkat
cells) and Figure S9D (HL-60 cells). Although NEM
completely blocked mBBr labeling, no significant changes
in cellular GSH (p > 0.09) were noted with 50 µg/mL of
either SBA-15 or MCM-41. Even at 200 µg/mL, neither
nanoparticle had a significant effect on cellular GSH after a
6 h incubation (data not shown).
Finally, we evaluated the effects of nanoparticles on
respiration of isolated mitochondria and submitochondrial
particles (SMP). Mitochondria or SMP were suspended in
10 mM Tris-Cl (pH 8.2), 250 mM sucrose, 2 µM Pd
phosphor, and 0.5% albumin with and without SBA-15 or
MCM-41. Concentrations of 50, 100, and 200 µg/mL were
used for both nanoparticles. Succinate (10 mM) was added
Figure 6. (A) HL-60 cells (0.5 × 106 per mL) were incubated at 37 °C for indicated periods of time without or with 200 µg/mL SBA-15
or 200 µg/mL MCM-41. ATP levels were measured three to five times for each condition at t ) 1–6 h. Open circles, no addition; filled
squares, 200 µg/mL SBA-15; filled triangles, 200 µg/mL MCM-41. (B) The experiment in panel A was repeated in the presence of 10 mM
NaCN. Open circles, NaCN alone; closed squares, NaCN plus 200 µg/mL SBA-15; closed triangles, NaCN plus 200 µg/mL MCM-41.
Standard deviations are indicated with error bars.
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at t ∼30 min to initiate respiration and NaCN (10 mM) was
added later on to terminate respiration. The results of one
set of experiments are given in Figure 7; when these
experiments were repeated, results (k-values) were quite
comparable to those in Figure 7. The same was true for the
cell respiration experiments.
For SBA-15 and mitochondria (Figure 7A), [O2] was
monitored continuously to 100 min. Oxygen concentrations
for 30 < t < 75 min were fitted to straight lines. The k-value
(µM O2/min) for mitochondria without SBA-15 was 3.38
(r2 ) 0.986), for mitochondria with 50 µg/mL 1.83 (r2 )
0.987), for mitochondria with 100 µg/mL 1.51 (r2 ) 0.962),
and for mitochondria with 200 µg/mL 0.92 (r2 ) 0.942).
These values correspond, respectively, to inhibitions of 46%,
55%, and 73%. Figure 7B shows [O2] for treated and
untreated SMP. The k-value for untreated SMP was 2.96 (r2
) 0.990), for SMP treated with 50 µg/mL 1.56 (r2 ) 0.997),
for SMP treated with 100 µg/mL 0.64 (r2 ) 0.948), and for
SMP treated with 200 µg/mL 0.41 (r2 ) 0.882). These
correspond to inhibitions of 47%, 78%, and 86%, respec-
tively.
For MCM-41 and mitochondria (Figure 7C), [O2] was
monitored continuously out to 130 min, with 10 mM
succinate added at t ) 40 min and NaCN at t ) 100 min.
Results for 40 < t < 100 min were fitted to lines to obtain
k-values. The k-value (µM O2/min) for untreated mitochon-
dria was 2.43 (r2 ) 0.993), for mitochondria treated with
50 µg/mL 1.17 (r2 ) 0.965), for mitochondria treated with
100 µg/mL 1.20 (r2 ) 0.978), and for mitochondria treated
with 200 µg/mL 1.08 (r2 ) 0.987). These values correspond
to inhibitions of 52%, 51%, and 56%, respectively. Figure
7D shows the results for SMP, untreated or treated with
MCM-41. The k-value for untreated SMP was 7.20 (r2 )
0.985), for SMP treated with 50 µg/mL 4.22 (r2 ) 0.984),
for SMP treated with 100 µg/mL 2.46 (r2 ) 0.989), and for
SMP treated with 200 µg/mL 1.23 (r2 ) 0.971). These
correspond to inhibitions of 41%, 66%, and 83%, respec-
tively. In all conditions, O2 consumption was completely
inhibited with NaCN.
Cellular respiration includes the delivery of O2 to mito-
chondria, the breakdown of reduced fuels (e.g., succinate)
with passage of electrons to O2 (forming H2O), and the
resulting synthesis of ATP. Toxins frequently target mito-
chondria and impair oxidative phosphorylation. We have
measured cellular respiration and ATP content in the
presence of two types of mesoporous silica nanoparticles,
SBA-15 and MCM-41 (Figure 1). Cyanide markedly inhib-
ited respiration and ATP content, establishing that both
processes occurred in association with oxidations in the
respiratory chain. Thus, reactive oxygen species did not
contribute significantly to the observed O2 consumption. That
cellular GSH remained unchanged (Figure S7 in Supporting
Figure 7. Effects of nanoparticles on respiration of isolated mitochondria and submitochondrial particles (SMP). Mitochondria or SMP
(15–20 µg/mL) were suspended in 10 mM Tris-Cl (pH 8.2), 250 mM sucrose, 2 µM Pd phosphor, and 0.5% albumin with and without
SBA-15 (A, mitochondria; B, SMP) or MCM-41 (C, mitochondria; D, SMP). Concentrations of 0 (open circles), 50 (triangles), 100 (squares),
and 200 (closed circles) µg/mL were used for both nanoparticles. Zero minutes corresponds to the addition of nanoparticles. Succinate (10
mM) was added to initiate respiration and NaCN (10 mM) to terminate respiration.
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Information) in the presence of nanoparticles further con-
firmed the negligible role of ROS.
Our results show SBA-15 interferes with cellular respira-
tion, whereas MCM-41 has no effect (Figure 2). This must
be connected with the different physical properties of
mesoporous silica nanoparticles (e.g., shape, size, and pores,
Figures S1-S3). Inhibition is proportional to dosing for
concentrations e100 µg/mL but levels off thereafter (Figure
S4 in Supporting Information). This may suggest that not
all mitochondria are equally susceptible to SBA-15 (e.g.,
mitochondria near the cell membrane may be more vulner-
able). The mitochondrial injury also depends nonmonotoni-
cally on incubation time with SBA-15 (Figure 2C). For 50
or 100 µg/mL SBA-15, the impairment of respiration
increased with exposure time up to 3 h and then decreased,
indicating time-dependent inhibition, with recovery. The time
dependence of cellular ATP (Figure 6A) paralleled that of
inhibition of cellular respiration. For 200 µg/mL, the inhibi-
tion did not decrease at long times, indicating recovery was
impossible for cells exposed to this high concentration.
If the particles are considered to be spheres of diameter
500 nm and density 2.5 g/cm3, each particle has a mass of
1.64 × 10-13 g, and 200 µg/mL corresponds to 1.22 × 109
particles/mL. With 106 cells per mL, this means 1200
particles per cell. The mean Jurkat cell volume, determined
on the Coulter model Z2 (Beckman Coulter, Inc.) was 1.7
× 10-13 L, which is 2600 times the volume of a nanoparticle.
The surface area of a Jurkat cell is calculated, assuming
spherical cells with radius 3.4 × 10-6 m, as 1.5 × 10-10 m2,
which is 760 times the cross-sectional area of a nanoparticles.
However, it is not known whether the particles are internal-
ized or attached to the cell surface. We did, however, perform
a number of experiments to elucidate the mechanism of
respiration inhibition.
First, we measured respiration of cells depleted of meta-
bolic fuels (Figure 3). Introduction of glucose led to an
increase in respiration rate, but not immediately. The delay
(t1) reflects the time required for cellular glucose uptake,
generation of reduced metabolic fuels via glycolysis, trans-
port of the fuels into the mitochondria, etc. At a later time
(t2) NaCN was injected to shut down respiration. We fitted
measured [O2] as a function of t to a three-line function,
with the third line horizontal. This involved choosing values
of five parameters, including k (rate of respiration), t1, and
t2, to produce the best fit.. With 50 µg/mL SBA-15, t1
increased by 12 min and k decreased by 44%; the corre-
sponding numbers for 200 µg/mL SBA-15 were 34 min and
56% (Figure 3A). These results confirm concentration-
dependent interference by SBA-15 in glucose-supported
respiration. With MCM-41, there was little effect on the
k-values (Figure S6 in Supporting Information). However,
there was an increase in the delay time t1 with increasing
MCM-41 concentration, similar to that of SBA-15 (Figure
3). Thus MCM-41 affects glucose processing but not
respiration.
Second, we measured cellular ATP levels in the presence
of 50 or 200 µg/mL nanoparticles. There was little change
in ATP concentration with time with 50 µg/mL of either
nanoparticle, whereas cyanide decreased cellular ATP by
39% within 1 h (Figure 5). However, 200 µg/mL SBA-15
(but not MCM-41) significantly diminished cellular ATP
(Figure 6A). Compared to untreated cells, the ATP level in
SBA-15-treated cells was 23% lower at hour 1, 41% lower
at hour 2, and fully recovered at hour 6. This parallels the
inhibition profile of SBA-15 on respiration (Figure 2C). The
results with cyanide present of Figure 6B confirm that ATP
hydrolysis (consumption) is not significantly altered in the
nanoparticle-treated cells.
Third, cellular GSH was measured without and with 50
µg/mL SBA-15 or MCM-41 (Figure S7A-B in Supporting
Information). Measurements were made on samples taken
every hour and the results fitted to exponentials. The values
of the exponential parameters were about the same for the
three conditions in both cell types, suggesting minimal effect
of nanoparticles on cellular GSH. Even at a nanoparticle
concentration of 200 µg/mL, there was no significant effect
on cellular GSH at 6 h (Figure S7 C-D in Supporting
Information). Thus, it is unlikely that significant ROS was
generated in the nanoparticle-treated cells.
Finally, we measured the respiration of mitochondria and
SMP (prepared by sonication of mitochondria) in the
presence of the nanoparticles (Figure 7). For the SMP, the
substrate (succinate) is in direct contact with complex II of
the respiratory chain, whereas substrate delivery is needed
for the mitochondria. (To test this definitively, intact rat liver
mitochondria exhibiting a high level of respiratory control
are necessary.) Both SBA-15 and MCM-41 were equally
toxic to the mitochondria and SMP.
Thus, it appears that the physical properties of nano-
particles determine their effects on cellular bioenergetics.
Cyanide-sensitive oxidative phosphorylation is inhibited in
cells exposed to SBA-15, which has lower specific surface,
larger size, and larger pores than MCM-41. Although its
smaller pores may limit entry of essential biomolecules,
MCM-41 has only a small effect on cellular respiration. Our
results suggest that the minimal effect of MCM-41 is likely
due to limited access to cellular mitochondria. The cellular
uptake of MCM-41 may be hindered by its high surface area
per unit mass.
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